Solventum Company Description
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.
It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V.
site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wrap, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers.
Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents.
The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms.
Its Purification and Filtration segment provides purification and filtration technologies comprising filters, purifiers, cartridges, and membranes.
The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce.
Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.
Country | United States |
Founded | 2023 |
Industry | Orthopedic, Prosthetic, and Surgical Appliances and Supplies |
Employees | 22,000 |
CEO | Bryan Hanson |
Contact Details
Address: 3M Center Maplewood, Delaware 55144-1000 United States | |
Phone | 651 733 1110 |
Website | solventum.com |
Stock Details
Ticker Symbol | 0AD1 |
Exchange | London Stock Exchange |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Bryan Hanson | Chief Executive Officer |
Wayde McMillan | Chief Financial Officer |
Amy Wakeham | Head of Investor Relations |